Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells
- PMID: 24391639
- PMCID: PMC3867683
- DOI: 10.3389/fimmu.2013.00455
Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells
Abstract
Under conditions of chronic antigen stimulation, such as persistent viral infection and cancer, CD8 T cells may diminish effector function, which has been termed "exhaustion." Expression of inhibitory Receptors (iRs) is often regarded as a hallmark of "exhaustion." Here we studied the expression of eight different iRs by CD8 T cells of healthy humans, including CTLA-4, PD1, TIM3, LAG3, 2B4, BTLA, CD160, and KLRG1. We show that many iRs are expressed upon activation, and with progressive differentiation to effector cells, even in absence of long-term ("chronic") antigenic stimulation. In particular, we evaluated the direct relationship between iR expression and functionality in CD8 T cells by using anti-CD3 and anti-CD28 stimulation to stimulate all cells and differentiation subsets. We observed a striking up-regulation of certain iRs following the cytokine production wave, in agreement with the notion that iRs function as a negative feedback mechanism. Intriguingly, we found no major impairment of cytokine production in cells positive for a broad array of iRs, as previously shown for PD1 in healthy donors. Rather, the expression of the various iRs strongly correlated with T cell differentiation or activation states, or both. Furthermore, we analyzed CD8 T cells from lymph nodes (LNs) of melanoma patients. Interestingly, we found altered iR expression and lower cytokine production by T cells from metastatic LNs, but also from non-metastatic LNs, likely due to mechanisms which are not related to exhaustion. Together, our data shows that expression of iRs per se does not mark dysfunctional cells, but is rather tightly linked to activation and differentiation. This study highlights the importance of considering the status of activation and differentiation for the study and the clinical monitoring of CD8 T cells.
Keywords: CD8 T cell; T cell exhaustion; activation; differentiation; inhibitory receptors.
Figures






Similar articles
-
Inhibitory Receptors Beyond T Cell Exhaustion.Front Immunol. 2015 Jun 26;6:310. doi: 10.3389/fimmu.2015.00310. eCollection 2015. Front Immunol. 2015. PMID: 26167163 Free PMC article. Review.
-
Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells.Cancers (Basel). 2022 Jan 10;14(2):323. doi: 10.3390/cancers14020323. Cancers (Basel). 2022. PMID: 35053490 Free PMC article.
-
Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.PLoS Pathog. 2010 Jun 10;6(6):e1000947. doi: 10.1371/journal.ppat.1000947. PLoS Pathog. 2010. PMID: 20548953 Free PMC article.
-
Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization.PLoS One. 2012;7(2):e30852. doi: 10.1371/journal.pone.0030852. Epub 2012 Feb 8. PLoS One. 2012. PMID: 22347406 Free PMC article.
-
The immune system in extreme longevity.Exp Gerontol. 2008 Feb;43(2):61-5. doi: 10.1016/j.exger.2007.06.008. Epub 2007 Jul 4. Exp Gerontol. 2008. PMID: 17870272 Review.
Cited by
-
Polyfunctional Melan-A-specific tumor-reactive CD8(+) T cells elicited by dacarbazine treatment before peptide-vaccination depends on AKT activation sustained by ICOS.Oncoimmunology. 2016 Feb 1;5(5):e1114203. doi: 10.1080/2162402X.2015.1114203. eCollection 2016 May. Oncoimmunology. 2016. PMID: 27467927 Free PMC article.
-
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells.J Clin Invest. 2018 Nov 1;128(11):4912-4923. doi: 10.1172/JCI120612. Epub 2018 Sep 24. J Clin Invest. 2018. PMID: 30130255 Free PMC article.
-
Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non-Small Cell Lung Cancer.Cancer Immunol Res. 2019 Jun;7(6):896-909. doi: 10.1158/2326-6066.CIR-18-0713. Epub 2019 May 3. Cancer Immunol Res. 2019. PMID: 31053597 Free PMC article.
-
Hypomethylating agents in combination with immune checkpoint inhibitors in acute myeloid leukemia and myelodysplastic syndromes.Leukemia. 2018 May;32(5):1094-1105. doi: 10.1038/s41375-018-0070-8. Epub 2018 Feb 22. Leukemia. 2018. PMID: 29487386 Free PMC article. Review.
-
Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.Cancer Cell. 2017 Mar 13;31(3):311-325. doi: 10.1016/j.ccell.2017.02.008. Cancer Cell. 2017. PMID: 28292435 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials